9233 - Cancer: Drugs (Answered)

Debbie Abrahams
To ask the Secretary of State for Health, pursuant to the Answer of 26 June 2015 to Question 3177, on the Cancer Drugs Fund, whether it is still his policy to continue to invest in the Cancer Drugs Fund.

George Freeman

The Government remains committed to continuing to invest in the Cancer Drugs Fund and this year £340 million has been provided so people in England get the cancer drugs they need.

9315 - Cancer: Drugs (Answered)

Debbie Abrahams
To ask the Secretary of State for Health, whether the prioritisation process for treatments on the National Cancer Drugs Fund list will take place in 2015-16.

George Freeman

The Cancer Drugs Fund panel considered a number of drug/indications for reprioritisation in July 2015. The panel’s decisions were announced on 4 September 2015 and are available at:

www.england.nhs.uk/ourwork/pe/cdf/cdf-drug-sum/

8971 - Drugs: Licensing (Answered)

Nick Thomas-Symonds
To ask the Secretary of State for Health, what steps his Department has taken to act upon the outcomes of the stakeholder roundtable discussion it convened on 11 February 2015 on access to off-patent drugs.

George Freeman

The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.

8970 - Drugs: Licensing (Answered)

Nick Thomas-Symonds
To ask the Secretary of State for Health, what the outcome was of the stakeholder roundtable discussion on off-patent drugs convened by his Department on 11 February 2015.

George Freeman

The Department convened a roundtable event on 11 February 2015 to discuss what action, could most expeditiously be taken to ensure that robust evidence about new uses for existing drugs is produced, disseminated and then used to inform clinical decision making about these medicines.

8974 - Drugs: Licensing (Answered)

Nick Thomas-Symonds
To ask the Secretary of State for Health, what progress has been made in implementing non-legislative measures to provide routine access on the NHS to off-patent drugs that have been proven to be clinically effective for new indications.

George Freeman

8973 - Drugs: Licensing (Answered)

Nick Thomas-Symonds
To ask the Secretary of State for Health, with which organisations and individuals (a) Ministers and (b) officials in his Department have discussed the availability of repurposed off-patent drugs on the NHS since 12 February 2014.

George Freeman

8722 - Pharmacy (Answered)

Mr Roger Godsiff
To ask the Secretary of State for Health, when patient records will be made available to commercial pharmacies.

George Freeman

8033 - Cancer: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what amount from the Cancer Drugs Fund is available to be spent by the Northern Ireland Executive in (a) 2015-16 and (b) 2016-17.

George Freeman

We have had no such discussions.

The Cancer Drugs Fund operates in England only and it is for the Northern Ireland Executive to make its own decisions on the commissioning and funding of cancer drugs based on its available resources and population needs.

8032 - Cancer: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what recent discussions he has had with his counterpart in the Northern Ireland Executive on the availability of drugs to treat cancer.

George Freeman

We have had no such discussions.

The Cancer Drugs Fund operates in England only and it is for the Northern Ireland Executive to make its own decisions on the commissioning and funding of cancer drugs based on its available resources and population needs.

8164 - Cancer: Drugs (Answered)

Andrew Gwynne
To ask the Secretary of State for Health, whether he plans for a new system for the reimbursement of cancer drugs to be in place by April 2016 when the current Cancer Drugs Fund is proposed to end.

George Freeman

NHS England has advised that the Cancer Drugs Fund in its current form is due to operate until 1 April 2016. We understand that NHS England and the National Institute for Health and Care Excellence will shortly be consulting jointly on a proposed new system for commissioning cancer drugs.

Pages